CD24 is a highly glycosylated protein with a small protein core that is linked to the plasma
membrane via a glycosyl‐phosphatidylinositol anchor. CD24 is primarily expressed by …

Malignant transformation is associated with abnormal glycosylation, resulting in the
synthesis and expression of altered carbohydrate determinants including sialyl Lewisa and …

Cancer patients are at high risk for venous thromboembolism (VTE). Laboratory parameters
with a predictive value for VTE could help stratify patients into high-or low-risk groups. The …

As a testament to the importance of CD24, researchers with diverse interests, including
adaptive immunity, inflammation, autoimmune diseases and cancer, have encountered …

OBJECTIVE.: CD24 is an established marker for poor prognosis in ovarian and other
carcinomas. Acquisition of cytoplasmic CD24, as opposed to membranous expression, has …

Purpose: CD24 is expressed in hematological malignancies as well as in a large variety of
solid tumors including breast cancer. We aimed to evaluate CD24 protein expression in …

The glycosylphosphatidylinositol-anchored membrane protein CD24 functions as an
adhesion molecule for P-selectin and L1 and plays a role in B-cell development and …

CD24 is a molecule that recently has raised considerable attention in tumour biology. It is
involved in cell adhesion and metastatic tumour spread. It has also been described as a new …

CD24 is a small heavily glycosylated glycosylphosphatidylinositol-linked cell surface
protein, which is expressed in hematological malignancies as well as in a large variety of …

With the goal of identifying genes with a differential pattern of expression between ovarian
serous papillary carcinomas (OSPCs) and normal ovarian (NOVA) epithelium and using this …